You have 9 free searches left this month | for more free features.

melanoma cancer

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Monitoring T Cell Responses in Melanoma, Lung and Other Cancer

Recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +9 more
  • Biospecimen Collection
  • Electronic Health Record Review
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Oct 4, 2023

Gut and Tumor Microbiome in Advanced ER-positive and

Not yet recruiting
  • Breast Cancer
  • Melanoma
  • Observation
  • (no location specified)
Nov 6, 2023

Prostate, Lung, Melanoma and Breast Cancer Patients Following

Recruiting
  • Prostate Cancer
  • +3 more
  • SBRT
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 4, 2023

Tumor Skin, Metastatic Melanoma, Melanoma Trial in Orlando, Louisville (OBX-115)

Active, not recruiting
  • Tumor Skin
  • +2 more
  • OBX-115
  • Orlando, Florida
  • +1 more
Sep 28, 2023

Melanoma Trial in Beijing (IBI363)

Not yet recruiting
  • Melanoma
  • IBI363
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Oct 7, 2023

PD-1 Refractory Advanced Melanoma Trial in Pittsburgh (Responder-Derived Fecal microbiota transplantation (R-FMT, Pembrolizumab,

Not yet recruiting
  • PD-1 Refractory Advanced Melanoma
  • Responder-Derived Fecal microbiota transplantation (R-FMT
  • +2 more
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Sep 1, 2023

Uveal Melanoma Trial in Grand Rapids (Darovasertib)

Recruiting
  • Uveal Melanoma
  • Grand Rapids, Michigan
    The Cancer and Hematology Centers
Jun 14, 2023

Melanoma Trial in Beijing, Nanjing, Hangzhou (OH2, Salvage chemo or best supportive care)

Recruiting
  • Melanoma
  • OH2
  • Salvage chemotherapy or best supportive care
  • Beijing, Beijing, China
  • +2 more
May 11, 2023

Melanoma Trial in Beijing City, Fuzhou City, Zhejiang (Atezolizumab, Bevacizumab)

Active, not recruiting
  • Melanoma
  • Beijing City, China
  • +2 more
Dec 13, 2022

Metastatic, Melanoma, Non Small Cell Lung Cancer (NSCLC) Trial in Philadelphia (Radiotherapy, MEDI4736, Tremelimumab)

Active, not recruiting
  • Metastatic
  • +4 more
  • Radiotherapy
  • +2 more
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Jan 6, 2023

Improve Early Detection of Cancer Recurrence in High-Risk

Recruiting
  • Stage III Melanoma
  • Stage IV Cutaneous Melanoma
    • Cleveland, Ohio
      Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
    Oct 6, 2022

    Advanced Malignant Solid Tumor, Stage III Cutaneous Melanoma AJCC v7, Stage III Prostate Cancer AJCC v7 Trial in New Brunswick

    Active, not recruiting
    • Advanced Malignant Solid Neoplasm
    • +9 more
    • New Brunswick, New Jersey
      Rutgers Cancer Institute of New Jersey
    Jan 25, 2023

    Metastatic Uveal Melanoma Trial in Tampa (ZIV-Aflibercept, Cemiplimab)

    Recruiting
    • Metastatic Uveal Melanoma
    • Tampa, Florida
      Moffitt Cancer Center
    Nov 2, 2023

    Uveal Melanoma Trial in Pittsburgh (Tebentafusp)

    Not yet recruiting
    • Uveal Melanoma
    • Pittsburgh, Pennsylvania
      UPMC Hillman Cancer Center
    Oct 5, 2023

    Melanoma Trial in Beijing (tunlametinib, paclitaxel +carboplatin, or temozolomide +cisplatin, or dacarbazine +cisplatin)

    Not yet recruiting
    • Melanoma
    • tunlametinib
    • paclitaxel +carboplatin, or temozolomide +cisplatin, or dacarbazine +cisplatin
    • Beijing, Beijing, China
      Beijing Cancer Hospital
    Aug 15, 2023

    Clinical Stage 0 Cutaneous Melanoma AJCC v8, Clinical Stage I Cutaneous Melanoma AJCC v8, Clinical Stage IA Cutaneous Melanoma

    Recruiting
    • Clinical Stage 0 Cutaneous Melanoma AJCC v8
    • +43 more
    • Best Practice
    • +7 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 12, 2022

    Non-melanoma Skin Cancer Trial in Dresden (optical coherence tomography, in vivo reflectance confocal microscopy, 3D total body

    Completed
    • Non-melanoma Skin Cancer
    • optical coherence tomography, in vivo reflectance confocal microscopy, 3D total body photography
    • Dresden, Saxony, Germany
      Klinik und Poliklinik für Dermatologie, Carl Gustav Carus Dresde
    Apr 24, 2023

    Metastatic Melanoma, Skin Cancer Trial in Boston (Ipilimumab, Nivolumab, Cryoablation)

    Not yet recruiting
    • Metastatic Melanoma
    • Skin Cancer
    • Boston, Massachusetts
      Massachusetts General Hospital Cancer Center
    Mar 9, 2023

    Melanoma, Breast Cancer, Oncology Trial in Saint-Petersburg

    Active, not recruiting
    • Melanoma
    • +7 more
      • Saint-Petersburg, Russian Federation
        N. N. Petrov Research Institute of oncology
      Sep 12, 2023

      Melanoma Recurrence With Circulating Tumor DNA (ctDNA)

      Active, not recruiting
      • Melanoma
        • Murray, Utah
        • +1 more
        Feb 17, 2023

        Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma Trial in

        Not yet recruiting
        • Clinical Stage III Cutaneous Melanoma AJCC v8
        • +4 more
        • Nashville, Tennessee
          Vanderbilt University/Ingram Cancer Center
        Feb 28, 2023

        NSCLC, Melanoma Trial (IMM60, Pembrolizumab)

        Not yet recruiting
        • Non-small Cell Lung Cancer
        • Melanoma
        • (no location specified)
        Jan 24, 2023

        Melanoma Stage III Trial in Shanghai (Toripalimab combined with Temozolomide)

        Not yet recruiting
        • Melanoma Stage III
        • Toripalimab combined with Temozolomide
        • Shanghai, China
          Fudan University Shanghai Cancer Center
        Apr 23, 2023

        Melanoma Trial in Boston (MCS110, Dabrafenib, Trametinib)

        Active, not recruiting
        • Melanoma
        • Boston, Massachusetts
          Dana Farber Cancer Institute
        Dec 14, 2022

        NSCLC, Non-small Cell Carcinoma, Histiocytic Tumor Trial (BDTX-4933)

        Not yet recruiting
        • Non-small Cell Lung Cancer
        • +32 more
        • (no location specified)
        Mar 30, 2023